Small scale industries (SSIs) in the Indian pharmaceutical sector have urged Prime Minister, Dr Manmohan Singh and UPA Chairperson, Sonia Gandhi to stop the proposed Central Drug Authority (CDA) bill from being tabled in the Parliament. They have alleged that the health ministry officials on the insistence of international pharma companies are pushing the bill in the forthcoming Parliament session.
Concerned over the promptness with which the CDA bill is being amended to be introduced in the approaching session of the Parliament, the SME Pharma Industries Confederation (SPIC) has written a letter to the PM and the UPA chief, seeking their intervention on the issue. The confederation, representing small pharma units, points out that preventing this bill from being placed in the Parliament would help save around 5000 SSIs from closing down. Small drug units produce nearly 40% of the total Rs 70,000 crore worth of medicines in the country and provide direct employment to a large number of people in the country.
Small pharma units fear that if the CDA bill is passed in the Parliament without incorporating the recommendations of the Amar Singh panel, their competitiveness would suffer.
For more information visit: http://www.bizxchange.in/
Saurabh Garg
2nd floor, Response
Times of India Bldg.
Dr.D.N. Road, Fort
Mumbai-400001
